The ZFPM2 mRNA expression levels of 69 glioma patients were examined using real-time qRT-PCR (Fig 4A), and the range and median levels of ZFPM2 total mRNA for the different subtypes and grades of glioma are shown in Table 4. The gene discussed is ZFPM2; the disease is central nervous system cancer.